Updated:
BGI Genomics Technology
BGI Genomics Technology began in 1999 under Wang Jian, who also chairs BGI Group. Wang Shi, founder of China Vanke, serves as co-chairman. The firm...
BGI Genomics Technology
BGI Genomics Technology began in 1999 under Wang Jian, who also chairs BGI Group. Wang Shi, founder of China Vanke, serves as co-chairman. The firm concentrates on genomics testing and research through its ownership stake in BGI Genomics. Investment activity centers on direct partnerships and joint ventures. A $50M collaboration with Natera covers oncology and reproductive health testing. Perennial Holdings participates in the BGI Perennial Genomics Diagnostic Imaging Centre. Geographic reach includes operations in China and the United States via Complete Genomics in Mountain View, California. Team size and total deployment remain undisclosed. The firm maintains BGI Health Foundation and Mammoth Foundation as separate philanthropic vehicles. Leadership holds roles in the Genetics Society of China and Chinese Society of Biotechnology.
General information
Firm type
Corporate Investor
Year founded
1999
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shenzhen
Corporate office
Shenzhen, China
Principals
Wang Jian
Co-founder and Chairman of BGI Group and BGI Genomics
Sector focus
Frequently asked questions
Who runs investment decisions at BGI Genomics Technology?
Wang Jian serves as co-founder and chairman. Decisions align with the firm's role as controlling shareholder of BGI Genomics and its partnership agreements.
Does BGI Genomics Technology participate in fund commitments or only direct deals?
Activity centers on direct partnerships and joint ventures, including the Natera collaboration and Perennial Holdings venture.
Where does the underlying wealth come from?
The firm operates as a corporate investor tied to BGI Group genomics operations rather than family wealth.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: